BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8876842)

  • 1. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.
    Jonas HA; Kronmal RA; Psaty BM; Manolio TA; Meilahn EN; Tell GS; Tracy RP; Robbins JA; Anton-Culver H
    Ann Epidemiol; 1996 Jul; 6(4):314-23. PubMed ID: 8876842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
    Dubuisson JT; Wagenknecht LE; D'Agostino RB; Haffner SM; Rewers M; Saad MF; Laws A; Herrington DM
    Diabetes Care; 1998 Nov; 21(11):1790-6. PubMed ID: 9802722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group.
    Manolio TA; Furberg CD; Shemanski L; Psaty BM; O'Leary DH; Tracy RP; Bush TL
    Circulation; 1993 Nov; 88(5 Pt 1):2163-71. PubMed ID: 8222111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.
    Tremollieres FA; Cigagna F; Alquier C; Cauneille C; Pouilles J; Ribot C
    Atherosclerosis; 2000 Nov; 153(1):81-8. PubMed ID: 11058702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group.
    Tell GS; Polak JF; Ward BJ; Kittner SJ; Savage PJ; Robbins J
    Circulation; 1994 Dec; 90(6):2905-8. PubMed ID: 7994837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Nabulsi AA; Folsom AR; Szklo M; White A; Higgins M; Heiss G
    Circulation; 1996 Oct; 94(8):1857-63. PubMed ID: 8873660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers.
    Husak L; Vaccarino V; Veledar E; Murrah N; Wenger NK
    Am J Cardiol; 2004 Mar; 93(5):563-8. PubMed ID: 14996580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.
    O'Leary DH; Polak JF; Kronmal RA; Kittner SJ; Bond MG; Wolfson SK; Bommer W; Price TR; Gardin JM; Savage PJ
    Stroke; 1992 Dec; 23(12):1752-60. PubMed ID: 1448826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study.
    Le Gal G; Gourlet V; Hogrel P; Plu-Bureau G; Touboul PJ; Scarabin PY
    Atherosclerosis; 2003 Jan; 166(1):163-70. PubMed ID: 12482563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
    Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
    Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and age-related maculopathy in older women.
    Seitzman RL; Mangione C; Ensrud KE; Cauley JA; Stone KL; Cummings SR; Hochberg MC; Hillier TA; Yu F; Coleman AL
    Ophthalmic Epidemiol; 2008; 15(5):308-16. PubMed ID: 18850467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function.
    Jokela H; Dastidar P; Rontu R; Salomäki A; Teisala K; Lehtimäki T; Punnonen R
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4348-54. PubMed ID: 12970309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.